(Q45029002)

English

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Deep vein thrombosis in patients with multiple myeloma treated with thalidomide and chemotherapy: effects of prophylactic and therapeutic anticoagulation (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

0 references

0 references

0 references

anticoagulation

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

deep vein thrombosis

1 reference

based on heuristic

inferred from title

2

object named as

Bart Barlogie

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

3

object named as

Elias Anaissie

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Maurizio Zangari

1

object named as

Maurizio Zangari

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

11

object named as

Frits Van Rhee

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

author name string

Fariba Saghafifar

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Paul Eddlemon

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Joth Jacobson

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Choon-Kee Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Raymond Thertulien

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Giampaolo Talamo

9

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Teri Thomas

10

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Athanasios Fassas

12

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Louis Fink

13

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Guido Tricot

14

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

1 September 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

126

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

715-721

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Antitumor activity of thalidomide in refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Activated protein C resistance in the absence of factor V Leiden mutation is a common finding in multiple myeloma and is associated with an increased risk of thrombotic complications.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Thrombogenic activity of doxorubicin in myeloma patients receiving thalidomide: implications for therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Venous thromboembolism and cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2004.05078.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2004.05078.X

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45029002&oldid=2063426546"